Analyst Coverage
| Firm |
Analyst |
Phone |
| Barclays Capital
|
Doug Tsao |
+212 526 4160
|
| Deutsche Bank Securities
|
Ross Muken |
+212 250 7547
|
| Garp Research & Securities
|
Brett Carson |
+410 825 6600
|
| Goldman Sachs & Co.
|
Robert Jones |
+212 357 3336
|
| Jefferies & Company
|
David Windley |
+615 963 8313
|
| Lazard Capital Markets
|
Stephen Unger |
+212 632 1908
|
| Piper Jaffray
|
Sean Wieland |
+415 277 1518
|
| Raymond James & Associates
|
Sandy Draper |
+404 442 5888
|
| Robert W. Baird & Co.
|
Eric Coldwell |
+312 609 5467
|
| Thomas Weisel Partners
|
Steven Halper |
+212 271 3807
|
| Wells Fargo Securities
|
Greg Bolan |
+615 525 2418
|
| William Blair & Company
|
John Kreger |
+312 364 8597
|
Pharmaceutical Product Development is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Pharmaceutical Product Development's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Pharmaceutical Product Development or its management. Pharmaceutical Product Development does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
